(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7 Purity >99.5% (GC) ee >99.5% Factory
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (R)-1-Boc-3-Aminopiperidine (CAS: 188111-79-7) with high quality, commercial production. Ruifu Chemical offers a wide range of chiral compounds. We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Igama Lekhemikhali | (R)-1-Boc-3-Aminopiperidine |
Omqondofana | (R)-(-)-3-Amino-1-Boc-Piperidine;(R)-1-Boc-3-Piperidinamine;tert-Butyl (R)-3-Amino-1-Piperidinecarboxylate |
Inombolo ye-CAS | 188111-79-7 |
Inombolo yeCAT | I-RF-CC348 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C10H20N2O2 |
Isisindo samangqamuzana | 200.28 |
Ukuminyana | 1.041±0.060 g/cm3 |
I-Refractive Index | 1.473 |
Ukuncibilika kwamanzi | Okungahlangani Namanzi |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Uketshezi Olungenambala kuya Kuphuzi noma Okuqinile |
Okuqukethwe kwamanzi (KF) | <0.50% |
Ukuhlanzeka / Indlela Yokuhlaziya | >99.5% (GC) |
ee | >99.5% |
Ukuzungezisa Okuthile [α]20/D | -30.5° ~ -26.5° (C=1 ku-DMF) |
I-Infrared Spectrum | Ivumelana Nesakhiwo |
I-NMR | Ivumelana Nesakhiwo |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Chiral Compounds;Pharmaceutical Intermediates |
Iphakheji: Ibhodlela Elifakwe Fluorinated, 25kg/Drum, noma ngokwezidingo zekhasimende
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama
(R)-1-Boc-3-Aminopiperidine (CAS: 188111-79-7) isetshenziswa njengendawo ephakathi ekwenziweni kwezinto ezihlukahlukene ezifana nemithi.(R)-1-Boc-3-Aminopiperidine ingasetshenziswa njengesandulela sokulungiswa kwe-dipeptidyl peptidase IV inhibitors njenge-API (CAS:361442-04-8), i-Linagliptin (CAS: 668270-12-0), i-Alogliptin ( I-CAS: 850649-61-5), namanye ama-antidiabetic agents.(I-CAS: 361442-04-8) umuthi wesifo sikashukela sohlobo 2 ongashukumisa ama-pancreas ukuthi akhiqize i-insulin eyengeziwe ngemva kokudla.Ifinyelelwe ngokubambisana kwe-AstraZeneca kanye ne-Bristol-Myers Squibb Company futhi ingeye-DPP-IV inhibitor.Idlala indima ngokuvimbela ukuwohloka kwe-GLP-l.I-GLP-I amahomoni akhiqizwa ngokwemvelo emathunjini ngemva kokudla ukudla.(I-CAS:361442-04-8) ingalawula ukukhishwa kwe-insulin futhi iqinise ukusetshenziswa kwe-glucose ezicutshini ze-peripheral.Umuthi owodwa we-(CAS:361442-04-8) uthuthukisa ukulawulwa kweglucose yegazi kanye nemithi ehlanganisiwe ye-(CAS:361442-04-8) ene-metformin, sulfonylurea kanye ne-thiazolidinediones ingathuthukisa umphumela wokwelapha.Kuholela engcupheni ephansi ye-hypoglycemia futhi ukusabela kwayo okubi kuyefana ne-placebo, okubonisa ukubekezelelana okungcono.